View Clinical Trial (Medical Research Study)


A Multicenter Study to Evaluate the Efficacy of DR-105 for Menstrually-Related Migraine Headaches - NCT00781456-92123(Clinical Trial 715439)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  San Diego
State:  
CA
Zip Code: 92123
Conditions: Migraine
Purpose: This study is being conducted to evaluate the efficacy of DR-105 compared to placebo for decreasing the frequency and severity of menstrually-related migraine headaches.
Study summary: This is a multicenter, randomized, study to evaluate and compare the frequency and severity of menstrually-related migraine headaches before and during the 7-day ethinyl estradiol monotherapy interval in women treated with DR-105 compared to placebo during the 91-day treatment period.
Criteria: Inclusion Criteria: - Premenopausal, non-pregnant, non-lactating - History of migraine headaches without aura for at least 6 months - History of migraine headaches associated with menstruation - Others as directed by FDA-approved protocol Exclusion Criteria: - History of migraine headaches with aura or focal neurological symptoms - Any contraindication to the use of oral contraceptives - Others as dictated by FDA-approved protocol
Study is available at: Teva Investigational Site
San Diego, CA 92123
United States

Primary Contact:
Sally M Fedon, Pharm.D.
Email: medicalaffairs@barrlabs.com
Phone: 215-293-7279
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: March 22, 2011
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.